Immunic, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Immunic, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $32.00K.
- Immunic, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $2.75M, a 419.28% increase from fiscal 2019.
- Immunic, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $529.00K, a 10480.00% increase from fiscal 2018.
- Immunic, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $5.00K, a 0.00% change from fiscal 2017.
- Immunic, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $5.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $32.00K 10-Q · filed 2026-08-11 | |
| 2020-12-31 | $2.75M 10-K · filed 2021-02-26 | |
| 2019-12-31 | $529.00K 10-K · filed 2021-02-26 | |
| 2018-12-31 | $5.00K 10-K · filed 2019-03-04 | |
| 2017-12-31 | $5.00K 10-K · filed 2019-03-04 | |
| 2013-12-31 | $135.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |